Your session is about to expire
← Back to Search
Procedure
Microwave Ablation for Lung Cancer (MARK 1A Trial)
N/A
Waitlist Available
Led By Shanda Blackmon, MD, MPH
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
Does lung ablation improve clinical outcomes for patients deemed to be surgically high-risk?
Eligible Conditions
- Lung Cancer
- Lung Metastasis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Assessment of patient adverse events as defined by CTCAE.
Efficacy of microwave ablation.
Secondary study objectives
Pathological response in patients receiving microwave ablation.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Microwave AblationExperimental Treatment1 Intervention
Microwave Ablation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Microwave ablation
2011
N/A
~660
Find a Location
Who is running the clinical trial?
Medtronic - MITGIndustry Sponsor
262 Previous Clinical Trials
300,769 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,339 Previous Clinical Trials
3,062,136 Total Patients Enrolled
Shanda Blackmon, MD, MPHPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
11 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger